Home › Funds › PFM Health Sciences, LP › VERA
PFM Health Sciences, LP position in VERA
VERA THERAPEUTICS INC · Health Care
PFM Health Sciences, LP reported holding 224,289 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.6M, representing 0.84% of its reported portfolio and ranking #45 among its reported holdings. PFM Health Sciences, LP has disclosed VERA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's VERA position evolved
PFM Health Sciences, LP first disclosed a stake in VERA in Q3 2025 at 513,685 shares (US$14.9M). Across 4 filings, PFM Health Sciences, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 224,289 shares valued at US$9.6M — an increase of 49,422 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2025 (shares fell 21% over the following quarter), a 62% increase in Q1 2026 (shares rose 7% over the following quarter), a 28% increase in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 513.68K | $14.93M | New |
| Q4 2025 | 107.69K | $5.45M | Reduce |
| Q1 2026 | 174.87K | $7.03M | Add |
| Q2 2026 | 224.29K | $9.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 2.89M sh · $124.01M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
- Davern Capital Partners, LP 498.83K sh · $21.40M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held VERA?
PFM Health Sciences, LP has disclosed VERA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is PFM Health Sciences, LP's current position in VERA?
As of Q2 2026, PFM Health Sciences, LP holds 224.29K shares of VERA (VERA THERAPEUTICS INC), valued at $9.62M, representing 0.84% of its reported portfolio and ranking #45.
Has PFM Health Sciences, LP been buying or selling VERA?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in VERA.
Which other funds hold VERA?
Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.